RxDoctor Payments Data

Samuel Ecker, DO

Dermatology · Laramie, WYNPI 1033555230

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.5% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 38.3% of the total.

$2,588in general payments, 2019–2025

Across 127 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$991
  • Lilly USA, LLC$292
  • Novartis$286
  • Johnson & Johnson$167
  • Regeneron Healthcare Solutions, Inc.$127
  • Pfizer$81
  • plus $646 from 20 others

What the payments were for

  • Food & beverage$2,47396%
  • Education$1154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few dermatology providers in Wyomingto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$648,028
Medicare patients
845
Services billed
5,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab14$94,774
Tacrolimus35$5,153
Clobetasol Propionate104$5,105
Doxycycline Hyclate191$3,307
Metronidazole28$1,245
Triamcinolone Acetonide117$1,174
Ketoconazole61$947
ValacyclovirValacyclovir Hcl37$598
Pentoxifylline12$586
Fluocinonide15$454
Minoxidil27$433
Hydroxychloroquine Sulfate25$378
Hydrocortisone59$273
Mupirocin22$176

Paid to pharmacies, not to this prescriber.

Other dermatology in Laramie

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →